Roberto E. Favoni

1.9k total citations
39 papers, 1.6k citations indexed

About

Roberto E. Favoni is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Roberto E. Favoni has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Roberto E. Favoni's work include Growth Hormone and Insulin-like Growth Factors (11 papers), Occupational and environmental lung diseases (10 papers) and Estrogen and related hormone effects (8 papers). Roberto E. Favoni is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (11 papers), Occupational and environmental lung diseases (10 papers) and Estrogen and related hormone effects (8 papers). Roberto E. Favoni collaborates with scholars based in Italy, United States and United Kingdom. Roberto E. Favoni's co-authors include Douglas Yee, Neal Rosen, Alessandra de Cupis, Gail S. Lebovic, Marc E. Lippman, K. J. Cullen, Soonmyoung Paik, Rachel Marcus, Tullio Florio and D.R. Powell and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Roberto E. Favoni

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto E. Favoni Italy	20	844	541	527	356	327	39	1.6k
Donata Vitagliano Italy	19	920 1.1×	1.0k 1.9×	587 1.1×	390 1.1×	228 0.7×	29	1.9k
Luis J. Leandro‐García Spain	20	781 0.9×	532 1.0×	315 0.6×	322 0.9×	476 1.5×	31	1.5k
Anna L. Stratford Canada	24	1.2k 1.5×	567 1.0×	503 1.0×	130 0.4×	445 1.4×	27	1.9k
Vasyl Vasko United States	21	659 0.8×	602 1.1×	882 1.7×	169 0.5×	293 0.9×	38	1.7k
Bianca Maria Veneziani Italy	22	1.0k 1.2×	821 1.5×	205 0.4×	689 1.9×	338 1.0×	51	2.0k
Minjing Zou Saudi Arabia	30	1.1k 1.3×	638 1.2×	1.0k 2.0×	163 0.5×	221 0.7×	71	2.1k
Rocío Letón Spain	20	457 0.5×	262 0.5×	373 0.7×	119 0.3×	403 1.2×	25	1.3k
Yuzo Furuya Japan	22	923 1.1×	510 0.9×	180 0.3×	731 2.1×	359 1.1×	83	1.9k
Francesco Trapasso Italy	26	1.5k 1.8×	375 0.7×	169 0.3×	119 0.3×	312 1.0×	74	2.0k
Fatima Rangwala United States	14	618 0.7×	557 1.0×	421 0.8×	284 0.8×	159 0.5×	34	1.6k

Countries citing papers authored by Roberto E. Favoni

Since Specialization

Citations

This map shows the geographic impact of Roberto E. Favoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto E. Favoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto E. Favoni more than expected).

Fields of papers citing papers by Roberto E. Favoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto E. Favoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto E. Favoni. The network helps show where Roberto E. Favoni may publish in the future.

Co-authorship network of co-authors of Roberto E. Favoni

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto E. Favoni. A scholar is included among the top collaborators of Roberto E. Favoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto E. Favoni. Roberto E. Favoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pattarozzi, Alessandra, Elisa Carra, Roberto E. Favoni, et al.. (2017). The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells. Stem Cell Research & Therapy. 8(1). 119–119. 19 indexed citations

Thellung, Stefano, Roberto E. Favoni, Roberto Würth, et al.. (2016). Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies. Current Drug Targets. 17(7). 824–849. 7 indexed citations

Favoni, Roberto E., Antonio Daga, Paolo Malatesta, & Tullio Florio. (2012). Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. British Journal of Pharmacology. 166(2). 532–553. 18 indexed citations

Favoni, Roberto E. & Angela Alama. (2012). Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout. Drug Discovery Today. 18(1-2). 11–24. 10 indexed citations

Favoni, Roberto E. & Tullio Florio. (2011). Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma. Trends in Pharmacological Sciences. 32(8). 463–479. 19 indexed citations

Pinton, Giulia, Warren Thomas, Roberto E. Favoni, et al.. (2010). Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib. PLoS ONE. 5(11). e14110–e14110. 52 indexed citations

Daga, Antonio, Daniela Marubbi, Maria Capra, et al.. (2009). Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors. Journal of Biological Chemistry. 284(11). 7138–7148. 114 indexed citations

Cupis, Alessandra de, Gennaro Schettini, & Roberto E. Favoni. (1999). NEWVSOLD FASHIONED OESTRADIOL ANTAGONISTS IN MAMMARY CARCINOMA: `IN VITRO' AND `IN VIVO' PHARMACOLOGICAL APPROACHES. Pharmacological Research. 39(5). 335–344. 6 indexed citations

Zugmaier, Gerhard, Roberto E. Favoni, Ruy Gastaldoni Jaeger, Neal Rosen, & Cornelius Knabbe. (1999). Polysulfated Heparinoids Selectively Inactivate Heparin‐Binding Angiogenesis Factors. Annals of the New York Academy of Sciences. 886(1). 243–248. 18 indexed citations

10.

Cupis, Alessandra de, Paolo Esposto Pirani, Laura Fazzuoli, & Roberto E. Favoni. (1998). Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: Comparison between early and late cultures. In Vitro Cellular & Developmental Biology - Animal. 34(10). 836–843. 3 indexed citations

11.

Cupis, Alessandra de & Roberto E. Favoni. (1997). Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens. Trends in Pharmacological Sciences. 18(7). 245–251. 23 indexed citations

12.

Cupis, Alessandra de, Marina Ciomei, Paolo Esposto Pirani, et al.. (1997). Anti‐insulin‐like growth factor‐I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines. British Journal of Pharmacology. 120(3). 537–543. 7 indexed citations

13.

Favoni, Roberto E., et al.. (1995). Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status. Journal of Cancer Research and Clinical Oncology. 121(11). 674–682. 28 indexed citations

14.

Favoni, Roberto E., Federica Ravera, Paolo Esposto Pirani, et al.. (1994). Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines. European Journal of Pharmacology. 264(2). 199–206. 7 indexed citations

15.

Favoni, Roberto E., Alessandra de Cupis, Federica Ravera, et al.. (1994). Expression and function of the insulin‐like growth factor I system in human non‐small‐cell lung cancer and normal lung cell lines. International Journal of Cancer. 56(6). 858–866. 52 indexed citations

16.

Ravera, Federica, Loredana Miglietta, Paolo Esposto Pirani, Silvano Ferrini, & Roberto E. Favoni. (1993). Suramin-induced growth inhibition and insulinlike growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events. European Journal of Cancer. 29(2). 225–230. 21 indexed citations

17.

Yee, Douglas, Roberto E. Favoni, Marc E. Lippman, & D.R. Powell. (1991). Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Research and Treatment. 18(1). 3–10. 70 indexed citations

18.

Yee, Douglas, Roberto E. Favoni, Ruth Lupu, et al.. (1989). The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochemical and Biophysical Research Communications. 158(1). 38–44. 53 indexed citations

19.

Yee, Douglas, Soonmyoung Paik, Gail S. Lebovic, et al.. (1989). Analysis of Insulin-Like Growth Factor I Gene Expression in Malignancy: Evidence for a Paracrine Role in Human Breast Cancer. Molecular Endocrinology. 3(3). 509–517. 354 indexed citations

20.

Alama, Angela, Pierfranco Conté, Eddi Di Marco, Roberto E. Favoni, & A Nicolin. (1986). Proliferative Activity of Human Solid Tumors Evaluated by Thymidine Labeling Index and Primer-Dependent α-DNA Polymerase. Oncology. 43(6). 385–389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact